Skip to main content

Table 3 Summary of the NGS-PGT-A and FET results for the 105 alleged mosaic blastocysts diagnosed by SNP array

From: The inconsistency between two major aneuploidy-screening platforms—single-nucleotide polymorphism array and next-generation sequencing—in the detection of embryo mosaicism

NGS-PGT-A and FET results

n (%)

NGS-PGT-A outcomes (n = 105)

 Euploid embryo

11 (10.48%)

 Aneuploid embryo

14 (13.33%)

 Mosaic embryo

80/105 (76.19%)

  Mosaic embryo with low aneuploid percentage (≤50%)

57/80 (71.25%)

  Mosaic embryo with high aneuploid percentage (> 50%)

23/80 (28.75%)

 Transferable embryo

68/105 (64.76%)

 Untransferable embryo

37/105 (35.24%)

FET outcomes (n = 21) a

 Not pregnant

5

 Biochemical pregnancy

15

 Clinical pregnancy

14

 Early miscarriage

2

 Ongoing pregnancy (under observation)

7

 Live birth

5

  1. a The incidence of each pregnancy outcome was not calculated because the FET outcomes of some embryos were under observation